Infliximab emerged as the lifeblood treatment for inflammatory conditions after its approval. This biological TNF-α-inhibiting monoclonal antibody boosts and improves the nidaamka difaaca jirka, bringing relief to patients with moderate to severe inflammatory disorders.
The Infliximab drug has proven effective in treating many conditions. The medication helps adult and paediatric patients with Cudurka Crohn, ulcerös kolit, rheumatoid arthritis (combined with methotrexate), ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.
Maqaalkani waxa uu bixiyaa faham faahfaahsan oo ku saabsan isticmaalka infliximab, qaadashada daawada, waxyeelooyinka iman kara, iyo wax kasta oo aad u baahan tahay inaad ka fikirto markaad isticmaalayso daawadan xoogga badan.
Infliximab waxay ka tirsan tahay fasalka cudurada bayoolojiga wax ka beddelaya dawooyinka ka hortagga laabotooyinka (bDMARDs). Daroogadu waxay ku dheggan tahay TNF-alpha waxayna dhexdhexaadisaa hawsheeda si loo yareeyo bararka unugyada saameeya.
Daawadu waxay daawaysaa dhowr xaaladood oo difaaca jirka ah bararka:
Dhakhaatiirtu waxay infliximab ku bixiyaan faleebo xididka oo qaata ugu yaraan 2 saacadood. Daaweyntu waxay ku bilaabataa qiyaasaha induction toddobaadyada 0, 2, iyo 6. Qiyaasaha dayactirku waxay raacaan 8dii toddobaadba mar, marka laga reebo ankylosing spondylitis, oo u baahan qiyaaso 6 toddobaadba mar. Xaaladdaada ayaa go'aamisa qiyaasta.
Dhibaatooyinka caadiga ah waa:
Saamaynta halista ah waxaa ka mid ah:
TNF-alpha (buro necrosis factor-alpha) waa borotiin kiciya caabuq xaaladaha nooc kasta ah. Infliximab waxay bartilmaantaa oo ku dhegtaa borotiinkan si ay u joojiso waxyeeladeeda. Daawadu waxay ku xidhan tahay TNF-alpha labadaba foomamka sabbaynaya xorta ah iyo unugyada, taas oo ka hortagaysa inay ku xidhmaan reseptors.
Daawadu sidoo kale:
Waa inaad ka taxadartaa isku-darka infliximab iyo daawooyinka qaarkood. Taxaddar dheeraad ah ayaa loo baahan yahay gaar ahaan marka aad leedahay:
Dhakhaatiirtu waxay ku bixiyaan infliximab IV, kaas oo qaata ugu yaraan 2 saacadood. Qorshaha daaweynta caadiga ah waxaa ka mid ah:
Daawadu waxay u baahan tahay qaboojiye inta u dhaxaysa 2-8°C ilaa laga gaadhayo wakhtiga isticmaalka.
Infliximab waxay ahayd door daawaynta muhiimka ah ee bukaanada qaba xaaladaha caabuqa ilaa iyo markii la ansixiyay. Daawadan bayooloji waxay xannibaysaa borotiinnada TNF-alfa waxayna yaraynaysaa bararka jidhka oo dhan. Bukaanka qaba cudurka Crohn, ulcerative colitis, rheumatoid arthritis-ka, iyo cudurrada kale ee difaaca jirka ayaa la kulmay nafis gaar ah daawayntan.
Infliximab waxay rajo siisaa bukaanada markii hore lahaa xulashooyin xaddidan. Daawadu waxay ka caawisaa dad aan tiro lahayn inay maareeyaan astaamahooda oo ay wanaajiyaan tayada noloshooda, inkastoo ay u baahan tahay maamul taxadar leh iyo la socosho. Kooxaha daryeelka caafimaadku waxay ahaanayaan ilaha ugu wanaagsan si loo go'aamiyo haddii daawayntani ku habboon tahay xaaladda gaarka ah ee bukaanka.
The medication comes with specific risks that doctors monitor carefully. Your body becomes more vulnerable to infections, particularly qaaxada and fungal infections. Some patients have developed lymphoma and other cancers. Your doctor will evaluate your risk factors and keep track of your health regularly to manage these risks.
Natiijooyinka waa ku kala duwan yihiin bukaanada. Dadka qaarkood waxay dareemaan fiicnaan 2-3 maalmood gudahooda markay daawaynta bilaabaan. Kuwa kale waxay u baahan karaan ilaa 6 toddobaad. Cilmi-baaristu waxay muujinaysaa in badi bukaannada colitis-ka ay ku jawaabaan siddeed toddobaad gudahood. Bogsiinta mindhicirka oo dhammaystiran waxay badiyaa u baahan tahay wakhti dheeraad ah.
Waa inaad isla markiiba wacdaa si aad ballan kale u hesho. Irbada soo socota ayaa la ballansan doonaa laba toddobaad ka dib. Weligaa ha isku dayin inaad dib u soo kabsato qiyaasta la seegay adiga oo laba jibaar qaadanaya.
Ma jiro dawo gaar ah oo loogu talagalay infliximab xad-dhaaf ah. Waxaad u baahan tahay gargaar caafimaad oo degdeg ah haddii aad ka shakisan tahay qaadashada xad dhaafka ah. Shaqaalaha caafimaadku waxay ilaalin doonaan falcelinta xun waxayna daweyn doonaan calaamadahaaga.
Waa inaadan qaadan infliximab haddii aad leedahay:
Daawadu waxay raacdaa jadwal gaar ah. Waxaad heli doontaa qiyaaso toddobaadyada 0, 2, iyo 6, ka dibna qiyaasaha dayactirka 8 toddobaad kasta. Xaaladdaada waxay ka caawisaa dhakhtarkaaga inuu go'aamiyo wakhtiga saxda ah.
Infliximab waxay u shaqeysaa sidii daaweyn waqti dheer ah. Bukaannada si fiican uga jawaaba waxay caadi ahaan sii wataan qiyaasaha dayactirka 8dii toddobaadba mar. Takhtarkaagu si joogto ah ayuu u fiiriyaa si uu u eego haddii ay tahay inaad sii wadato daawaynta.
Waxaa laga yaabaa inaad u baahato inaad joojiso qaadashada infliximab haddii:
Infliximab looguma talagalin isticmaalka maalinlaha ah. Daawadu waxay ku shaqeysaa jadwal gaar ah oo ka bilaabma qiyaasaha toddobaadyada 0, 2, iyo 6. Faleebooyinka dayactirka waxay raacaan 6-8 toddobaad kasta iyadoo ku saleysan xaaladdaada. Qaadashada maalin kasta waxay kordhin kartaa waxyeellooyin halis ah iyada oo aan wax faa'iidooyin dheeraad ah lahayn.
Jadwalka xaruntaada daryeelka caafimaadka ayaa go'aamiya wakhtiga maadaama infliximab u baahan tahay maamulka xididka ee goob caafimaad 2+ saacadood. Bukaanjiifka badankoodu waxay u arkaan ballamaha subaxda inay sida ugu fiican u shaqeeyaan. Shaqaalaha caafimaadku waxay la socon karaan falcelin kasta oo degdeg ah maalinta oo dhan.
Ka fogow:
Isbeddelka miisaanka ma aha waxyeellooyin caadi ah. Si kastaba ha ahaatee, bukaannada qaarkood waxay dareemaan isbeddello miisaan. Cunto isku dheeli tiran iyo jimicsi joogto ah ayaa weli lama huraan ah inta lagu jiro daawaynta.
Cuntadaadu uma baahna xaddidaadyo gaar ah. Si kastaba ha ahaatee, waa inaad ilaalisaa habka difaacaaga adigoo iska ilaalinaya: